Lancashire and South Cumbria
Formulary
Formulary
15 Anaesthesia
15-01-08 Drugs for malignant hyperthermia
Should only be administered by, or under the direct supervision of, personnel experienced in the use of dantrolene when used for malignant hyperthermia.
| Dantrolene Sodium |
|
Formulary
|
Injection 120mg vial |
 MHRA: Intravenous dantrolene: risk of undissolved crystals |
|
Links
LSCMMG: Inflammatory Bowel Disease: High Cost Drugs Commissioning Pathway- LSCMMG: Primary Care Constipation Guidelines
- MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- MHRA: Intravenous dantrolene: risk of undissolved crystals
- MHRA: IV dantrolene: risk of undissolved crystals�use a filter needle when drawing up reconstituted dantrolene solution
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people